Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate: A technical note

AAPS PharmSciTech

Volumn 8, Issue 1, 2007, Pages

  Gohel, Mukesh C ^a   Parikh, Rajesh K ^a   Brahmbhatt, Bansari K ^a   Shah, Aarohi R ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Coprocessing; Crospovidone; Disintegration; Dissolution; Sodium starch glycolate

Indexed keywords

DRUG DERIVATIVE; EXCIPIENT; POVIDONE; STARCH; STARCH GLYCOLATE SODIUM;

ARTICLE; CHEMISTRY; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; EVALUATION; MATERIALS TESTING; METHODOLOGY; SOLUBILITY;

DIFFUSION; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; EXCIPIENTS; MATERIALS TESTING; POVIDONE; SOLUBILITY; STARCH;

EID: 79951920089     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0801009     Document Type: Article

References (16)

1. Martin A. Drug Product Design. In: Physical Pharmacy. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:512-555.
2. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986:293-345.
3. Gohel MC, Jogani PD. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 2005;8:76-93.
4. Nachegari SK, Bansal AK. Coprocessed excipients for solid dosage forms. Pharm Technol. 2004;28:52-64.
5. Haldar R, Ray DB, Levin M. Screening of most effective superdisintegrant for the development of fast dissolving tablet formulation [abstract]. In: AAPSJ [serial online]. vol. Abstract W5221. 2005.
6. He X, Kibbe AH. Crospovidone. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association, London: Pharmaceutical Press; 2003:184-185.
7. Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech. 2005;6:E120-E126.
8. Miller RW. Sodium starch glycolate. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association, London: Pharmaceutical Press; 2003:581-584.
9. United States Pharmacopeia and National Formulary (USP 29 - NF 24). Rockville, MD: US Pharmacopeia; 2006.
10. Rios M. Developments in powder flow testing. Pharm Technol. 2006;30:38-49.
11. Shin SC, Oh IJ, Lee YB, Choi HK, Choi JS. Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone. Int J Pharm. 1998;175:17-24.
12. Alderborn G, Nystrom C. Pharmaceutical Powder Compaction Technology. New York, NY: Marcel Dekker, Inc; 1996.
13. Zhang Y, Chakrabarti S. Using excipient as binder. Manufacturing Chemist. 2003;74:61-62.
14. Rudnic E. Oral solid dosage forms. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy. 19th ed. Easton, PA: Mack Publishing Company; 1995:1615-1649.
15. Bolhuis GK, Zuurman K, Wierik GHP. Improvement of dissolution of poorly soluble drugs by solid deposition on a superdisintegrant. II. The choice of superdisintegrants and effect of granulation. Eur J Pharm Sci. 1997;5:63-69.
16. Inactive Ingredient Guide (Redacted). U.S. Food and Drug Administration, Center for Drug Evaluation and Research. January, 1996; Available at: http://www.fda.gov/cder/drug/iig/default.htm. Accessed June 18, 2006.